Modulation of soluble CD40 ligand bioactivity with anti-CD40 antibodies.

@article{Schwabe1997ModulationOS,
  title={Modulation of soluble CD40 ligand bioactivity with anti-CD40 antibodies.},
  author={Robert F. Schwabe and Simone Hess and Judith P. Johnson and Hartmut Engelmann},
  journal={Hybridoma},
  year={1997},
  volume={16 3},
  pages={217-26}
}
The B cell surface molecule CD40 may be activated either by its ligand CD40L or by anti-CD40 antibodies. In this study, five new anti-CD40 monoclonal antibodies (MAb) were characterized. Bioactivity of the MAb was assessed using a receptor hybrid consisting of the extracellular domain of CD40 and the intracellular domain of the p55 TNF receptor as a model for CD40 activation. Two agonistic MAb were able to enhance the activation of this CD40 hybrid CD40L. These MAb bound to an epitope that was… CONTINUE READING

From This Paper

Topics from this paper.